ArticleBMC gastroenterology2014

Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.

Wen-Yi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.